Fellows advance immunotherapy and tumour inflammation research
The University of Adelaide’s South Australian immunoGENomics Cancer Institute (SAiGENCI) has welcomed two new researchers through a fellowship program funded by the Ainsworth Foundation.
L-R: Dr Mara Zeissig and Professor Brendan Jenkins with Ainsworth Fellows, Dr Tamsin Lannagan and Dr Georgette Radford.
Dr Georgette Radford and Dr Tamsin Lannagan have joined Professor Brendan Jenkins’ Tumour Inflammation and Immunotherapy research program, with two more Ainsworth Fellows planned to join the team.
At least 25 per cent of cancers are associated with chronic inflammation, which is driven by the over-activation of innate and adaptive immune systems.
“There are a lot of unanswered questions around how inflammation can drive cancers, such as those of the lung, pancreas and stomach which are among the most lethal and common cancers worldwide” says Professor Jenkins.